MSB Trading - 2019, page-2673

First 2673 Last

Share
Profile

Follow
ddwn

12,354 Posts.

3368

19/09/19

17:46

Post #: 40485457
Share

Originally posted by stockrock ↑

I don't think they are far off, but a lot will depend on when the confirmatory trial starts.

The confirmatory trial will take 6-9 months to recruit ... 12 months to run... 3 months to read-out... then give it 9-12 months to file the BLA.. then another 6 months for an outcome from the FDA.. all that adds up to around 2023/24 approval and sales, assuming the trial starts sometime late next year (realistic).

The read-outs in 2020 will however be very strong indicators on whether or not the program is worth multi-billions of dollars in a few years time.. or zero. So the price sensitive nature of these trial results will be significant.

The short term goal for MSB is to have a positive phase 3 read-out in the two phase 3 trials... but shortly behind that is the approval of its near-term revenue generator ... pediatric GVHD will be the cash-cow to fund the short to mid-term until CLBP and CHF are ready to hit the market ... but before they do, you can count on new MPC's being developed that will need to be funded in pre-clinicals, phase 1 and phase 2 trials.. which will then form the next generation of programs to push Mesoblast into 2030's (these treatments take at least 10 years to develop from conceptual to approved product).

The road to a multi-billion dollar company is not a short one.. and whilst we will be looking at an inflection point in 3-6 months time... it won't be the last one.. there will be many along the way.

Expand

Hey, glad you are back posting
Your absence (low posting), was missed

MSB Price at posting: $2.01 Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

NXM

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

SFX

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

NIM

Nimy extends sulphide targets at Mons with new anomalies identified

There are more pages in this discussion • 1,752 more messages in this thread...

First 2673 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last 98.0¢		Change 0.010(1.03%)		Mkt cap ! $1.118B

Open	High	Low	Value	Volume
96.0¢	99.0¢	95.5¢	$5.286M	5.409M

Buyers (Bids)

No.	Vol.	Price($)
3	91218	98.0¢

Sellers (Offers)

Price($)	Vol.	No.
99.0¢	63577	4

View Market Depth

No.	Vol.	Price($)
3	91218	0.980
42	307626	0.975
14	519246	0.970
6	149303	0.965
8	166210	0.960

Price($)	Vol.	No.
0.990	63577	4
0.995	68052	2
1.000	121535	11
1.005	55374	2
1.010	10000	1

Last trade - 16.10pm 27/06/2024 (20 minute delay)

MSB (ASX) Chart

MSB Trading - 2019, page-2673

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

Nimy extends sulphide targets at Mons with new anomalies identified

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MSB Trading - 2019, page-2673

Top Stories

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Drilling at Bethanga shows signs of Cu-Au porphyry system for Nexus

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Sheffield Resources achieves milestone production, shipments at Thunderbird, WA

Nimy extends sulphide targets at Mons with new anomalies identified

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News